Foscarnet Decreases Human Immunodeficiency Virus RNA

Kaiser, Laurent; Perrin, Luc; Hirschel, Bernard; Furrer, Hansjakob; Von Overbeck, Jan; Olmari, Maya; Yerly, Sabine (1995). Foscarnet Decreases Human Immunodeficiency Virus RNA. Journal of infectious diseases, 172(1), pp. 225-227. The University of Chicago Press 10.1093/infdis/172.1.225

Preview

Text 172-1-225.pdf - Published Version Available under License Publisher holds Copyright. Download (256kB) | Preview

Foscarnet inhibits human immunodeficiency virus (HIV) replication in vitro and decreases p24 antigenemia in patients with cytomegalovirus (CMV) retinitis. To evaluate the effect of foscarnet on HIV replication, HIV RNA was quantitated in 17 patients before and during foscarnet therapy. Fifteen patients had CMV retinitis, 1 had CMV encephalitis, and 1 had intractable zoster. A decrease in HIV RNA was observed in 16 of 17 patients. Before the introduction of foscarnet, mean HIV RNA was 5.82 ± 0.24 log RNA/mL and, after a median of 13 days of therapy, mean HIV RNA was 5.30 ± 0.27 log RNA/mL (P < .001). Among patients with detectable p24 antigen at baseline, a significant decrease was observed (P = .017). This decrease in HIV RNA demonstrates that foscarnet is a potent antiretroviral drug.

Interest & Impact

Downloads

162 since deposited on 15 Oct 2020
15 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item